Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Navigating US payer evidence needs to optimise market access

What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How...

Petauri Evidence

- PMLiVE

AstraZeneca/Avillion share positive phase 3 results for asthma rescue treatment Airsupra

The chronic respiratory disease is estimated to affect up to 262 million people globally

- PMLiVE

J&J’s Erleada shows overall survival benefit in head-to-head prostate cancer study

Approximately 300,000 new cases of the disease are diagnosed in the US every year

- PMLiVE

ICR researchers reveal benefits of personalised radiotherapy for bladder cancer patients

More than 130,000 patients are treated with radiotherapy on the NHS every year

- PMLiVE

Medscape Education Breathes Life Into Pulmonology: Showcasing Success at CHEST 2024

Medscape Education showcases its strong track record in providing high-quality education in the field of pulmonology at the annual conference of the American College of Chest Physicians in Boston, Massachusetts,...

Medscape Education

- PMLiVE

AbbVie shares promising late-stage results for Parkinson’s disease candidate tavapadon

Approximately 153,000 people in the UK are currently living with the neurodegenerative disorder

- PMLiVE

ABPI highlights importance of NHS-industry partnerships in improving patient outcomes

Hospitals engaging in industry partnerships were found to be up to 2.5 times more likely to follow NICE guidelines

- PMLiVE

AstraZeneca gains rights to CSPC’s lipid-lowering therapy in deal worth over $1.9bn

Dyslipidaemia is estimated to result in 2.6 million global deaths every year

- PMLiVE

Bristol Myers Squibb’s Opdivo regimen granted FDA approval in NSCLC

More than 200,000 people are diagnosed with lung cancer in the US every year

- PMLiVE

Chiesi Group invests €400m to establish biotech centre of excellence in Italy

The facility is dedicated to developing and producing monoclonal antibodies, enzymes and other proteins

- PMLiVE

Researchers develop new approach to target cells affected by motor neurone disease

The technique could lead to safer and more effective gene therapies for the neurodegenerative disease

- PMLiVE

Top-10 ways for Pharma to leverage AI according to…AI

Like most people these days, I have been experimenting with various artificial intelligence (AI) tools this past year. It’s remarkable to see the progress made in the technology compared to...

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links